MedPath

Effect of Remazolam on Hemodynamics During Hepatectomy

Phase 4
Not yet recruiting
Conditions
Hemodynamic Instability
Registration Number
NCT06565715
Lead Sponsor
Jun Zhang
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not yet recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Inclusion Criteria:<br><br> 1. Patients who sign informed consent and are willing to complete the study according<br> to the plan;<br><br> 2. Over 18 years of age;<br><br> 3. ASA grade ? ~ ?;<br><br> 4. Elective surgery;<br><br> 5. General anesthesia combined with epidural anesthesia;<br><br> 6. Child Pugh is classified as Level A<br><br>Exclusion Criteria:<br><br> 1. Abnormal coagulation function;<br><br> 2. Abnormal platelet;<br><br> 3. A history of drug dependence;<br><br> 4. Neurological diseases;<br><br> 5. Severe sinus bradycardia (HR<50 beats/min);<br><br> 6. Atrial fibrillation;<br><br> 7. Systolic blood pressure =200mmHg and/or diastolic blood pressure =120mmHg.<br><br> 8. Cardiac insufficiency.<br><br> 9. Child Pugh is classified as B or C.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hemodynamic instability score
Secondary Outcome Measures
NameTimeMethod
Cardiac index (CI);Stroke volume variation (SVV);Systemic vascular resistance index (SVRI);Complications in 1 week after surgery
© Copyright 2025. All Rights Reserved by MedPath